Cargando…

Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development

Recent progress in molecular imaging has provided new important knowledge for further understanding the time course of early pathological disease processes in Alzheimer's disease (AD). Positron emission tomography (PET) amyloid beta (Aβ) tracers such as Pittsburgh Compound B detect increasing d...

Descripción completa

Detalles Bibliográficos
Autor principal:	Nordberg, Agneta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308023/ https://www.ncbi.nlm.nih.gov/pubmed/22136152 http://dx.doi.org/10.1186/alzrt96

Ejemplares similares

A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer’s disease
por: Almkvist, Ove, et al.
Publicado: (2023)

Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?
por: Jellinger, Kurt A, et al.
Publicado: (2008)

Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer's Disease
por: Leclerc, Benoît, et al.
Publicado: (2013)

Biomarkers for Alzheimer’s Disease Early Diagnosis
por: Ausó, Eva, et al.
Publicado: (2020)

Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
por: Zhang, Ying, et al.
Publicado: (2021)

Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
por: Bucci, Marco, et al.
Publicado: (2021)

Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective
por: Fontana, Igor C., et al.
Publicado: (2023)

Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
por: Mohanty, Rosaleena, et al.
Publicado: (2023)

Correction: Associations between different tau‑PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
por: Mohanty, Rosaleena, et al.
Publicado: (2023)

Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s Disease
por: Villa, Chiara, et al.
Publicado: (2022)

Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach
por: Salvatore, Christian, et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018)

Neuroprotection and Neuroregeneration in Alzheimer's Disease
por: Sugaya, Kiminobu, et al.
Publicado: (2012)

The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer’s Disease and Parkinson’s Disease
por: Pawlik, Patrycja, et al.
Publicado: (2021)

Biological subtypes of Alzheimer disease: A systematic review and meta-analysis
por: Ferreira, Daniel, et al.
Publicado: (2020)

Advances in the development of new biomarkers for Alzheimer’s disease
por: Klyucherev, Timofey O., et al.
Publicado: (2022)

CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer’s Disease
por: Karami, Azadeh, et al.
Publicado: (2019)

Biomarkers for Alzheimer’s Disease Diagnosis
por: Mantzavinos, Vasileios, et al.
Publicado: (2017)

Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease
por: Lilja, Anna M., et al.
Publicado: (2013)

microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
por: Siedlecki-Wullich, Dolores, et al.
Publicado: (2021)

Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer’s Disease
por: Hameed, Shahul, et al.
Publicado: (2020)

Protein and Imaging Biomarkers in the Eye for Early Detection of Alzheimer’s Disease
por: Fereshetian, Shaunt, et al.
Publicado: (2021)

PET Molecular Imaging in Drug Development: The Imaging and Chemistry Perspective
por: Nerella, Sridhar Goud, et al.
Publicado: (2022)

Perspectives in Lipocalin-2: Emerging Biomarker for Medical Diagnosis and Prognosis for Alzheimer's Disease
por: Song, Juhyun, et al.
Publicado: (2018)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer’s Disease
por: Fortea, Juan, et al.
Publicado: (2023)

Developing Biomarkers for the Skin: Biomarkers for the Diagnosis and Prediction of Treatment Outcomes of Alzheimer’s Disease
por: Wu, Ching-Ying, et al.
Publicado: (2023)

[(18)F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer’s disease
por: Chiotis, Konstantinos, et al.
Publicado: (2020)

Diagnosis and biomarkers of predementia in Alzheimer's disease
por: Forlenza, Orestes V, et al.
Publicado: (2010)

CSF Biomarkers for Alzheimer's Disease Diagnosis
por: Anoop, A., et al.
Publicado: (2010)

Alzheimer’s Disease, Diagnosis and the Need for Biomarkers
por: Hooper, Claudie, et al.
Publicado: (2008)

A review of brain imaging biomarker genomics in Alzheimer’s disease: implementation and perspectives
por: Li, Lanlan, et al.
Publicado: (2022)

Molecular and Imaging Biomarkers in Alzheimer’s Disease: A Focus on Recent Insights
por: Villa, Chiara, et al.
Publicado: (2020)

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer’s disease
por: Kadir, Ahmadul, et al.
Publicado: (2011)

In vivo Brainstem Imaging in Alzheimer’s Disease: Potential for Biomarker Development
por: Braun, David J., et al.
Publicado: (2018)

Promise and Challenge: The Lens Model as a Biomarker for Early Diagnosis of Alzheimer's Disease
por: Tian, Tian, et al.
Publicado: (2014)

Use of ocular biomarkers as a potential tool for early diagnosis of Alzheimer's disease
por: Singh, Ajay K, et al.
Publicado: (2020)

Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
por: Dubois, Bruno, et al.
Publicado: (2023)

Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
por: Pais, Marcos, et al.
Publicado: (2020)

Cost-Effectiveness of Magnetic Resonance Imaging with a New Contrast Agent for the Early Diagnosis of Alzheimer's Disease
por: Biasutti, Maria, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f59ikuncb8dke7imph4v2u1qia